Citigroup’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Other funds holding PMVP
BCM
EC
Citigroup's PMVP Position: Q3 2026 in Review
Citigroup sold out of PMV Pharmaceuticals (PMVP) in Q3 2026, closing a stake of 19,296 shares — an estimated $25.9K sold.
Citigroup first reported a position in PMVP in Q4 2020 and held it in 23 quarters. The position peaked at $7.42M in Q2 2022. 65 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.
- Citigroup reported no remaining PMV Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Citigroup sold 19,296 PMV Pharmaceuticals shares in Q3 2026, an estimated $25.9K.
- Citigroup first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 23 quarters.
- Citigroup's PMV Pharmaceuticals position peaked at $7.42M in Q2 2022.
- 65 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.